NCT01948388View on ClinicalTrials.gov

The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Rheumatoid Arthritis
Interventions
DRUG

corticotrophin 80 units

Comparison of different dosages of the drug. Ten patients will receive 80 units of corticotrophin weekly. Ten patients will receive 80 units bi-weekly of corticotrophin

Trial Locations (1)

33180

AARDS Research, Inc, Aventura

All Listed Sponsors
lead

Gaylis, Norman B., M.D.

INDIV

NCT01948388 - The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients | Biotech Hunter | Biotech Hunter